Statistics
Publications
13
Citations
2.7K
H-Index
12
Active since
2007
Jens Quant is an author at Boehringer Ingelheim (Austria) specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2024
13
13
BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Frank Hilberg, Gerald J. Roth, Martin Krššák et al. · Cancer Research · 2008 · 1.1K citations · Full text
Medicine, Oncology, Pharmacology +17
BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
Martin Steegmaier, Matthias Hoffmann, Anke Baum et al. · Current Biology · 2007 · 849 citations · Full text
Medicine, Oncology, Pharmacology +14
Targeting cancer with small-molecule pan-KRAS degraders
Johannes Popow, William Farnaby, Andreas Gollner et al. · Science · 2024 · 158 citations · Full text
Harald Weinstabl, Matthias Treu, Joerg Rinnenthal et al. · Journal of Medicinal Chemistry · 2019 · 87 citations · Full text
1–5 of 13